Methods regarding the measurements of the oxidative stress index via total (anti-)oxidative capacities as well as the quantification of (apoptotic) MNCs and CPCs (angiogenic and non-angiogenic precursor cells) via flow cytometry were published previously (Schmid et al., 2020).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.